ImmuneBridge

San Francisco, CA · Founded 2018 · Privately Held (backing)

Developer of allogeneic cellular immunotherapies designed for advancing cancer treatment. ImmuneBridge is based in San Francisco, CA and was founded in 2018. Its last reported valuation was $25 million in Jan 2023. It has raised $19.7 million across 2 recorded rounds; the latest was a $5.6 million early-stage round in Mar 2025.

Last reported valuation
$25.0M
Oct 2026
Priced at
—
Total raised
$19.7M
Last round
Early Stage VC
Mar 2025
How much has ImmuneBridge raised?
$19.7Macross 2 recorded rounds · Dec 2022 – Mar 2025

Most recently, ImmuneBridge raised $5.6M in its Early Stage VC (Mar 2025).

Free account
More of ImmuneBridge with a free account
  • ·The complete investor list: 16 names
  • ·Watch ImmuneBridge: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ImmuneBridge round by round

2 rounds
Mar 2025Early Stage VC$5.6MSEC filing▮
6 investors participated
Dec 2022Early Stage VC$10.2MSEC filing▮
15 investors participated

How much has ImmuneBridge raised?

ImmuneBridge has raised $19.7 million across 2 recorded rounds since 2022. The largest was a $5.6 million early-stage round in Mar 2025.

ImmuneBridge has filed 2 Form Ds with the SEC since 2023, most recently in Apr 2025 ($5.6 million sold to 6 investors).

ImmuneBridge investors

16 investors are on record for ImmuneBridge, including Pioneer Fund, Insight Partners (New York), Gaingels and Calm Ventures. By type, the record holds 7 venture capital firms and 1 private equity firm. The early-stage round in Mar 2025 drew 6 investors.

For fundraisers
Raising for a company like ImmuneBridge?

16 investors have backed ImmuneBridge.

See all 16 investors →

Frequently asked about ImmuneBridge

How much has ImmuneBridge raised?
ImmuneBridge has raised $19.7M in total across 2 recorded funding rounds.
When was ImmuneBridge's last funding round?
ImmuneBridge's most recent recorded round was Early Stage VC in Mar 2025, raising $5.6M.